Stocks Overview

LAST PRICE
105.5500
TODAY'S CHANGE (%)
Trending Down-0.8400 (-0.7895%)

Bid / Lots
104.5500/ 4
Ask / Lots
106.6600/ 1
Open / Previous Close
104.4400 / 106.3900
Day Range
Low 103.4900
High 106.8550
52 Week Range
Low 43.8900
High 111.0200
Volume
464,283
average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Thursday's close: 106.39
Time	Volume	BPMC
09:32 ET	4021	104.685
09:34 ET	500	103.65
09:36 ET	10498	105.91
09:38 ET	300	106.72
09:43 ET	850	105.7
09:45 ET	100	105.7
09:48 ET	672	105.705
09:50 ET	1253	106.62
09:52 ET	500	106.625
09:54 ET	700	106.3475
09:56 ET	800	106.5
09:57 ET	500	106.41
09:59 ET	927	106.455
10:01 ET	1331	106.44
10:03 ET	500	106.35
10:06 ET	9379	106.57
10:08 ET	2910	105.84
10:10 ET	100	105.74
10:12 ET	600	105.2325
10:14 ET	300	105.27
10:15 ET	100	105.34
10:17 ET	100	105.35
10:19 ET	2720	105.71
10:26 ET	385	105.76
10:28 ET	100	105.92
10:30 ET	100	106.42
10:32 ET	1480	105.905
10:33 ET	400	105.885
10:35 ET	826	105.4875
10:37 ET	3800	105.385
10:39 ET	100	105.4075
10:42 ET	944	104.42
10:44 ET	400	104.755
10:46 ET	500	104.805
10:48 ET	400	105.22
10:50 ET	6017	105.515
10:51 ET	349	105.65
10:53 ET	400	105.63
10:55 ET	288	105.44
10:57 ET	5959	105.345
11:00 ET	800	105.355
11:02 ET	4512	105.33
11:04 ET	1100	104.995
11:06 ET	1000	104.78
11:08 ET	800	104.695
11:09 ET	300	104.65
11:11 ET	100	104.72
11:15 ET	100	104.925
11:18 ET	500	104.775
11:20 ET	975	104.385
11:22 ET	200	104.53
11:27 ET	700	104.79
11:29 ET	166	104.89
11:36 ET	355	104.87
11:38 ET	100	104.87
11:42 ET	600	104.54
11:44 ET	200	104.53
11:45 ET	100	104.38
11:47 ET	200	104.27
11:51 ET	600	104.355
11:54 ET	1313	104.66
11:56 ET	100	104.825
11:58 ET	528	104.96
12:00 ET	1080	104.98
12:03 ET	100	104.96
12:05 ET	480	104.87
12:07 ET	462	104.82
12:09 ET	100	104.71
12:12 ET	2736	105.005
12:18 ET	200	104.58
12:21 ET	300	104.11
12:23 ET	400	104.405
12:25 ET	100	104.09
12:27 ET	100	104.405
12:30 ET	900	104.3
12:32 ET	200	104.32
12:36 ET	600	104.335
12:38 ET	200	104.35
12:39 ET	500	104.71
12:48 ET	554	104.525
12:54 ET	100	104.54
12:56 ET	200	104.41
12:57 ET	100	104.53
12:59 ET	600	104.64
01:03 ET	606	104.7
01:08 ET	301	104.745
01:10 ET	876	104.91
01:17 ET	200	104.98
01:19 ET	300	104.97
01:26 ET	800	104.73
01:28 ET	1478	104.94
01:33 ET	351	104.95
01:35 ET	200	104.81
01:37 ET	300	104.7
01:39 ET	305	104.69
01:42 ET	100	104.56
01:44 ET	1182	104.365
01:46 ET	1702	104.11
01:48 ET	2452	104.28
01:50 ET	400	104.27
01:55 ET	151	104.235
01:57 ET	100	103.92
02:00 ET	200	103.99
02:04 ET	500	104.05
02:08 ET	301	104.16
02:15 ET	200	104.02
02:18 ET	1651	104.24
02:20 ET	100	104.2183
02:22 ET	400	104.43
02:24 ET	100	104.54
02:27 ET	100	104.88
02:29 ET	300	104.885
02:31 ET	100	104.99
02:33 ET	1477	104.55
02:38 ET	1020	104.69
02:40 ET	100	104.44
02:42 ET	100	104.5
02:44 ET	100	104.61
02:45 ET	100	104.61
02:47 ET	865	104.91
02:49 ET	200	104.78
02:51 ET	517	104.91
02:54 ET	1476	104.825
02:58 ET	2395	105.125
03:00 ET	2178	105.335
03:02 ET	200	105.335
03:03 ET	3484	105.56
03:05 ET	500	105.51
03:07 ET	322	105.46
03:09 ET	799	105.62
03:12 ET	990	105.75
03:14 ET	900	105.61
03:16 ET	2889	105.44
03:18 ET	4035	105.05
03:20 ET	500	105.11
03:23 ET	800	105.33
03:25 ET	300	105.29
03:27 ET	900	105.26
03:30 ET	200	105.33
03:32 ET	10477	105.2
03:34 ET	900	105.57
03:36 ET	300	105.645
03:38 ET	2439	105.05
03:39 ET	600	105.26
03:41 ET	3466	105.5127
03:43 ET	500	105.39
03:45 ET	2510	105.2961
03:48 ET	1525	105.375
03:50 ET	1600	105.59
03:52 ET	1900	105.715
03:54 ET	1598	105.805
03:56 ET	2270	105.82
03:57 ET	6029	105.475
03:59 ET	59766	105.55

Data delayed at least 15 minutes.

Yesterday
- Investors Have the Opportunity to Join the Following Securities Fraud Investigations: Avangrid, Inc. (AGR), Squarespace, Inc. (SQSP), and Blueprint Medicines Corporation (BPMC), from 5:00PM ET on Thursday Jun 13, 2024 by Dow Jones
  5:00PM ET on Thursday Jun 13, 2024 by Dow Jones
Jun 12, 2024
- Currently, Investigations Into Potential Violations Of Securities Laws For The Investors Of Blueprint Medicines Corporation (NASDAQ:BPMC) Are Being Conducted By The Schall Law Firm, from 4:06PM ET on Wednesday Jun 12, 2024 by Dow Jones
  4:06PM ET on Wednesday Jun 12, 2024 by Dow Jones
Jun 11, 2024
- Currently, The Schall Law Firm Is Undertaking Probes Into Possible Breaches Of Securities Laws For The Benefit Of Blueprint Medicines Corporation (NASDAQ:BPMC) Investors, from 1:51PM ET on Tuesday Jun 11, 2024 by Dow Jones
  1:51PM ET on Tuesday Jun 11, 2024 by Dow Jones
Jun 9, 2024
- Currently, The Schall Law Firm is Actively Probing Possible Securities Law Breaches for the Benefit of Investors of Blueprint Medicines Corporation (NASDAQ:BPMC), from 11:05AM ET on Sunday Jun 09, 2024 by Dow Jones
  11:05AM ET on Sunday Jun 09, 2024 by Dow Jones
Jun 8, 2024
- Presently, The Schall Law Firm is Conducting Investigations into Potential Securities Law Violations for the Advantage of Investors of Blueprint Medicines Corporation (NASDAQ:BPMC), from 11:02AM ET on Saturday Jun 08, 2024 by Dow Jones
  11:02AM ET on Saturday Jun 08, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesBPMC Blueprint Medicines Corp	6.6B	-21.9x	---
United StatesRVMD Revolution Medicines Inc	6.6B	-10.3x	---
United StatesLEGN Legend Biotech Corp	8.3B	-16.3x	---
United StatesCRSP CRISPR Therapeutics AG	5.5B	-23.5x	---
United StatesCYTK Cytokinetics Inc	6.3B	-10.0x	---
United StatesITCI Intra-Cellular Therapies Inc	7.2B	-58.8x	---
As of 2024-06-14

Blueprint Medicines Corporation is a global precision therapy company that is inventing life-changing medicines in two areas of allergy/inflammation and oncology/hematology. The Company delivers its approved medicines, including AYVAKIT/AYVAKYT (avapritinib) and GAVRETO (pralsetinib), to patients in the United States and Europe, and it is globally advancing multiple programs for systemic mastocytosis (SM), lung cancer, breast cancer and other genomically defined cancers, and cancer immunotherapy. Its pipelines also include Elenestinib (BLU-263) (KIT), AYVAKIT (avapritinib) (KIT), Wild-type KIT research program, GAVRETO (pralsetinib) (RET), BLU-945 (EGFR), BLU-525 (EGFR), BLU-451 (EGFR exon 20 insertions), BLU-222 (CDK2), AYVAKIT (PDGFRA), GAVRETO (RET), BLU-222 (CDK2) and BLU-852 (MAP4K1). It is developing elenestinib (BLU-263), an investigational, orally available, potent and highly selective KIT inhibitor, for the treatment of indolent SM and other mast cell disorders.

Contact Information

Headquarters: 45 Sidney StreetCAMBRIDGE, MA, United States 02139
Phone: 617-374-7580
Fax: 302-655-5049

Executives

Chairman of the Board: Jeffrey Albers
President, Chief Executive Officer, Director: Kathryn Haviland
Chief Financial Officer: Michael Landsittel
President - Research and Development: Fouad Namouni
Chief Operating Officer: Christina Rossi

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$6.7B
Revenue (TTM)	$282.2M
Shares Outstanding	62.6M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	0.63
EPS	$-4.82
Book Value	$2.14
P/E Ratio	-21.9x
Price/Sales (TTM)	23.6
Price/Cash Flow (TTM)	---
Operating Margin	-94.69%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Blueprint Medicines Corp
NASDAQ:BPMCUnited States

Search Criteria

Charts

Recent News

Yesterday

Investors Have the Opportunity to Join the Following Securities Fraud Investigations: Avangrid, Inc. (AGR), Squarespace, Inc. (SQSP), and Blueprint Medicines Corporation (BPMC), from 5:00PM ET on Thursday Jun 13, 2024 by Dow Jones

Jun 12, 2024

Currently, Investigations Into Potential Violations Of Securities Laws For The Investors Of Blueprint Medicines Corporation (NASDAQ:BPMC) Are Being Conducted By The Schall Law Firm, from 4:06PM ET on Wednesday Jun 12, 2024 by Dow Jones

Jun 11, 2024

Currently, The Schall Law Firm Is Undertaking Probes Into Possible Breaches Of Securities Laws For The Benefit Of Blueprint Medicines Corporation (NASDAQ:BPMC) Investors, from 1:51PM ET on Tuesday Jun 11, 2024 by Dow Jones

Jun 9, 2024

Currently, The Schall Law Firm is Actively Probing Possible Securities Law Breaches for the Benefit of Investors of Blueprint Medicines Corporation (NASDAQ:BPMC), from 11:05AM ET on Sunday Jun 09, 2024 by Dow Jones

Jun 8, 2024

Presently, The Schall Law Firm is Conducting Investigations into Potential Securities Law Violations for the Advantage of Investors of Blueprint Medicines Corporation (NASDAQ:BPMC), from 11:02AM ET on Saturday Jun 08, 2024 by Dow Jones

Biotechnology Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar